Clopidogrel/aspirin - Yuhan
Alternative Names: Aspirin/clopidogel - Yuhan; YH 14659Latest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Yuhan
- Class 2 ring heterocyclic compounds; Antiplatelets; Antipyretics; Chlorobenzenes; Esters; Pyridines; Salicylic acids; Small molecules; Thienopyridines
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide stimulants; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Coronary disorders
Most Recent Events
- 01 Apr 2012 Yuhan Corporation completes a Phase I trial for Coronary disorders (in healthy volunteers) in South Korea (NCT01657071)
- 01 Mar 2012 Yuhan Corporation initiates enrolment in a Phase-I trial for Coronary disorders (in healthy volunteers) in South Korea
- 31 Dec 2011 Yuhan completes a Phase-I trial in healthy volunteers in South Korea (NCT01422109)